Correlation Between Century Therapeutics and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Neoleukin Therapeutics, you can compare the effects of market volatilities on Century Therapeutics and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Neoleukin Therapeutics.
Diversification Opportunities for Century Therapeutics and Neoleukin Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Century and Neoleukin is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Century Therapeutics and Neoleukin Therapeutics
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Neoleukin Therapeutics. In addition to that, Century Therapeutics is 1.05 times more volatile than Neoleukin Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest 43.00 in Neoleukin Therapeutics on August 25, 2024 and sell it today you would earn a total of 26.00 from holding Neoleukin Therapeutics or generate 60.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.99% |
| Values | Daily Returns |
Century Therapeutics vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Century Therapeutics |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Century Therapeutics and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Neoleukin Therapeutics
The main advantage of trading using opposite Century Therapeutics and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Century Therapeutics vs. Eliem Therapeutics | Century Therapeutics vs. HCW Biologics | Century Therapeutics vs. RenovoRx | Century Therapeutics vs. Tempest Therapeutics |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |